190 related articles for article (PubMed ID: 12496714)
1. [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain].
Clermont-Gnamien S; Atlani S; Attal N; Le Mercier F; Guirimand F; Brasseur L
Presse Med; 2002 Nov; 31(39 Pt 1):1840-5. PubMed ID: 12496714
[TBL] [Abstract][Full Text] [Related]
2. Are oral cannabinoids safe and effective in refractory neuropathic pain?
Attal N; Brasseur L; Guirimand D; Clermond-Gnamien S; Atlami S; Bouhassira D
Eur J Pain; 2004 Apr; 8(2):173-7. PubMed ID: 14987627
[TBL] [Abstract][Full Text] [Related]
3. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.
Johnson JR; Lossignol D; Burnell-Nugent M; Fallon MT
J Pain Symptom Manage; 2013 Aug; 46(2):207-18. PubMed ID: 23141881
[TBL] [Abstract][Full Text] [Related]
4. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
Karst M; Salim K; Burstein S; Conrad I; Hoy L; Schneider U
JAMA; 2003 Oct; 290(13):1757-62. PubMed ID: 14519710
[TBL] [Abstract][Full Text] [Related]
5. Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain.
Haroutiunian S; Rosen G; Shouval R; Davidson E
J Pain Palliat Care Pharmacother; 2008; 22(3):213-7. PubMed ID: 19042851
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
[TBL] [Abstract][Full Text] [Related]
7. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
[TBL] [Abstract][Full Text] [Related]
8. Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study.
Rintala DH; Fiess RN; Tan G; Holmes SA; Bruel BM
Am J Phys Med Rehabil; 2010 Oct; 89(10):840-8. PubMed ID: 20855984
[TBL] [Abstract][Full Text] [Related]
9. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
Ellis RJ; Toperoff W; Vaida F; van den Brande G; Gonzales J; Gouaux B; Bentley H; Atkinson JH
Neuropsychopharmacology; 2009 Feb; 34(3):672-80. PubMed ID: 18688212
[TBL] [Abstract][Full Text] [Related]
10. [Tetrahydrocannabinol for treatment of chronic pain].
Elsner F; Radbruch L; Sabatowski R
Schmerz; 2001 Jun; 15(3):200-4. PubMed ID: 11810357
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.
Narang S; Gibson D; Wasan AD; Ross EL; Michna E; Nedeljkovic SS; Jamison RN
J Pain; 2008 Mar; 9(3):254-64. PubMed ID: 18088560
[TBL] [Abstract][Full Text] [Related]
12. Cannabis constituent synergy in a mouse neuropathic pain model.
Casey SL; Atwal N; Vaughan CW
Pain; 2017 Dec; 158(12):2452-2460. PubMed ID: 28885457
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
Eisenberg E; Ogintz M; Almog S
J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789
[TBL] [Abstract][Full Text] [Related]
14. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.
de Vries M; Van Rijckevorsel DC; Vissers KC; Wilder-Smith OH; Van Goor H
Br J Clin Pharmacol; 2016 Mar; 81(3):525-37. PubMed ID: 26505163
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.
Serpell M; Ratcliffe S; Hovorka J; Schofield M; Taylor L; Lauder H; Ehler E
Eur J Pain; 2014 Aug; 18(7):999-1012. PubMed ID: 24420962
[TBL] [Abstract][Full Text] [Related]
16. THC and gabapentin interactions in a mouse neuropathic pain model.
Atwal N; Casey SL; Mitchell VA; Vaughan CW
Neuropharmacology; 2019 Jan; 144():115-121. PubMed ID: 30312630
[TBL] [Abstract][Full Text] [Related]
17. The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.
Naef M; Curatolo M; Petersen-Felix S; Arendt-Nielsen L; Zbinden A; Brenneisen R
Pain; 2003 Sep; 105(1-2):79-88. PubMed ID: 14499423
[TBL] [Abstract][Full Text] [Related]
18. Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief.
Schley M; Legler A; Skopp G; Schmelz M; Konrad C; Rukwied R
Curr Med Res Opin; 2006 Jul; 22(7):1269-76. PubMed ID: 16834825
[TBL] [Abstract][Full Text] [Related]
19. Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Lorente Fernández L; Monte Boquet E; Pérez-Miralles F; Gil Gómez I; Escutia Roig M; Boscá Blasco I; Poveda Andrés JL; Casanova-Estruch B
Neurologia; 2014 Jun; 29(5):257-60. PubMed ID: 24035293
[TBL] [Abstract][Full Text] [Related]
20. A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain.
Hoggart B; Ratcliffe S; Ehler E; Simpson KH; Hovorka J; Lejčko J; Taylor L; Lauder H; Serpell M
J Neurol; 2015 Jan; 262(1):27-40. PubMed ID: 25270679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
